Life Sciences
Top stories summarized by our editors
7/18/2018

Hy-Vee recalled its ready-to-eat Spring Pasta Salad after reports of about 20 individuals in four states sickened after consuming the product. The salads were packed in plastic containers, which were distributed to Hy-Vee's 244 grocery stores in Illinois, Iowa, Kansas, Minnesota, Missouri, Nebraska, South Dakota and Wisconsin.

Full Story:
Food Safety News
More Summaries:
Hy-Vee
7/18/2018

Akcea Therapeutics and Ionis Pharmaceuticals' Tegsedi, or inotersen, was approved by European regulators as a treatment for patients with the rare disease hereditary transthyretin amyloidosis, allowing doctors to prescribe it to patients with the disease who have stage I or II polyneuropathy.

7/18/2018

The FDA designated orphan drug status to Gamida Cell's NiCord, being developed to treat patients who are eligible for a hematopoietic stem cell transplantation.

Full Story:
eMPR
More Summaries:
Gamida Cell, FDA
7/18/2018

Nohla Therapeutics' dilanubicel, being developed to reduce morbidity and mortality associated with hematopoietic stem cell transplant, was given the FDA's orphan drug designation. The decision was backed by data from a midstage trial, in which treatment with dilanubicel led to a faster neutrophil and platelet recovery versus the control group, and infusion of the drug did not cause severe acute graft-versus-host disease or transplant-linked mortality.

Full Story:
eMPR
7/18/2018

European regulators have granted Lumendi approval for its single-use DiLumen Endolumenal Interventional Platform device, which facilitates visualization, diagnosis and treatment of large intestine conditions by providing endoscopic stability.

Full Story:
MedGadget
More Summaries:
EU
7/18/2018

Nova Biomedical was given 510(k) clearance by the FDA for StatStrip, a finger-stick capillary testing glucose meter, for critically ill patients with and without diabetes. The clearance was granted after studies showed the device's safety, efficacy and reliability.

More Summaries:
Nova Biomedical, FDA, StatStrip
7/18/2018

EpiBiome's high-throughput bacteriophage discovery platform was purchased by CRISPR-Cas3-engineered precision antibacterial products developer Locus Biosciences for an undisclosed amount. The deal will help Locus develop CRISPR-engineered phage antibiotic-resistant bacterial infection therapies.

More Summaries:
Locus, Locus Biosciences, EpiBiome
7/18/2018

The Sickle Cell Foundation of Georgia, Biotech Research Laboratories and the Phoenix Tears Foundation aim to raise $250,000 to advance an early-stage study to evaluate the safety and efficacy of medical cannabis oil to manage pain in sickle cell disease patients. Pain management is one way to improve the quality of life of SCD patients.

More Summaries:
medical cannabis, SCD, SCD
7/18/2018

A bumped-up initial public offering brought in $102 million for endocrine disease company Crinetics Pharmaceuticals, which has plans of advancing CRN00808 to a midstage acromegaly study in early 2019.

Full Story:
BioCentury
More Summaries:
Crinetics Pharmaceuticals
7/18/2018

Modern farming techniques such as plant biotechnology will help in meeting the global demand of producing 70% more food by 2050, writes Queensland Farmers' Federation President Stuart Armitage. Governments must ensure that unnecessary regulations do not prevent farmers from reaping the food supply and security benefits of biotech crops, he writes.